Thermo Fisher Scientific EPS Ratio 2011-2025 | TMO

EPS is a measure used to assess the financial stability and profitability of a company. EPS (Earnings Per Share) represents the company's net income divided by the number of its outstanding shares. This measure allows investors and analysts to evaluate the return on investment in the company's stock and compare it to other companies in the industry.

The term earnings per share (EPS) represents the portion of a company's earnings, net of taxes and preferred stock dividends, that is allocated to each share of common stock. The figure can be calculated simply by dividing net income earned in a given reporting period (usually quarterly or annually) by the total number of shares outstanding during the same term. Because the number of shares outstanding can fluctuate, a weighted average is typically used.
Calculated as:
EPS = (Net Income - Dividends on Preffered Stock) / Average Outstanding shares^[1]

EPS can be calculated as a simple ratio of net income to shares, or in various variations, such as diluted EPS, which takes into account the potential issuance of new shares or convertible securities.

A high EPS ratio usually indicates that the company has good profitability and efficiency in utilizing its assets. However, other factors such as sales growth, debt burden, and the company's competitive position should also be considered.

EPS ratio is an important indicator for investors when making decisions to buy or sell a company's stock. It is also used by analysts to assess the financial condition of the company and its potential for growth and development.

Annual EPS Ratio Thermo Fisher Scientific

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
16.6	15.5	17.8	19.6	16.1	9.24	7.31	5.64	5.12	4.96	4.76	3.53	3.24	3.49

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
19.6	3.24	9.49

Quarterly EPS Ratio Thermo Fisher Scientific

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
4.28	4.28	3.99	4.26	4.05	3.47	4.44	3.53	3.34	-	3.82	4.25	5.66	-	4.83	4.65	5.93	-	4.88	2.92	1.99	2.51	1.89	2.8	2.04	2.23	1.76	1.87	1.44	1.32	1.35	1.57	1.41	1.6	1.2	1.31	1.02	1.51	1.19	1.28	0.97	1.5	1.18	0.7	1.38	0.95	0.88	0.77	0.94	1.05	0.8	0.64	0.76	0.77	0.7	1.37	0.65

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
5.93	0.64	2.26

References

Khan, T. R., Islam, M. R., Choudhury, T. T., & Adnan, A. M. (2014). How earning per share (EPS) affects on share price and firm value.

EPS Ratio of other stocks in the Diagnostics research industry

Issuer	EPS Ratio	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	-2.06	$ 0.33	-6.23 %	$ 30.6 M	Germany
Global Cord Blood Corporation CO	4.12	$ 2.99	-	$ 399 M	China
Genetron Holdings Limited GTH	-1.08	$ 4.03	0.12 %	$ 80.1 M	China
Chembio Diagnostics CEMI	-0.72	$ 0.46	0.22 %	$ 16.8 M	USA
Pacific Biosciences of California PACB	-1.21	$ 2.23	-4.91 %	$ 566 M	USA
Koninklijke Philips N.V. PHG	3.67	$ 27.4	0.31 %	$ 20 B	Niderland
Meridian Bioscience VIVO	0.97	$ 33.97	-	$ 1.49 B	USA
HTG Molecular Diagnostics HTGM	-24.3	$ 0.48	-20.0 %	$ 1.06 M	USA
Quotient Limited QTNT	-1.21	$ 0.32	-11.32 %	$ 1.1 M	Schweiz
Bioventus BVS	-2.49	$ 6.58	0.38 %	$ 412 M	USA
Twist Bioscience Corporation TWST	-3.6	$ 31.45	-4.38 %	$ 1.82 B	USA
Heska Corporation HSKA	-1.92	$ 119.99	-	$ 1.31 B	USA
Motus GI Holdings MOTS	-15.9	$ 0.17	-34.28 %	$ 263 K	Israel
Biocept BIOC	-1.89	$ 0.43	-13.05 %	$ 7.29 M	USA
Syneos Health SYNH	2.26	$ 42.98	-	$ 4.46 B	USA
Invitae Corporation NVTA	-13.2	$ 0.09	-	$ 21.2 M	USA
DermTech DMTK	-3.09	$ 0.09	-11.32 %	$ 2.94 M	USA
Akumin AKU	-1.75	$ 0.29	-17.87 %	$ 25.9 M	Canada
Castle Biosciences CSTL	0.66	$ 25.99	1.9 %	$ 722 M	USA
DarioHealth Corp. DRIO	1.93	$ 13.51	-3.43 %	$ 383 M	Israel
Exagen XGN	-1.34	$ 11.86	1.63 %	$ 210 M	USA
PerkinElmer PKI	2.21	$ 115.24	-0.91 %	$ 14.7 B	USA
OpGen OPGN	2.44	$ 1.96	-16.95 %	$ 1.54 M	USA
DexCom DXCM	1.4	$ 59.78	2.68 %	$ 23.1 B	USA
Organovo Holdings ONVO	-1.7	$ 2.12	-2.3 %	$ 19.4 M	USA
Burning Rock Biotech Limited BNR	-14.2	$ 12.18	-9.51 %	$ 131 M	China
Danaher Corporation DHR	5.33	$ 214.2	-0.55 %	$ 157 B	USA
Neogen Corporation NEOG	-5.03	$ 6.26	1.46 %	$ 1.36 B	USA
Biomerica BMRA	-2.16	$ 2.71	-0.52 %	$ 6.23 M	USA
Fulgent Genetics FLGT	-1.41	$ 22.96	2.25 %	$ 694 M	USA
Psychemedics Corporation PMD	-0.72	$ 2.67	-1.84 %	$ 15.3 M	USA
Genetic Technologies Limited GENE	-0.08	$ 0.77	-	$ 7.1 B	Australia
Myriad Genetics MYGN	-1.41	$ 8.03	-0.19 %	$ 728 M	USA
Renalytix AI plc RNLX	-0.31	$ 0.21	5.66 %	$ 22.7 M	Britain
Medpace Holdings MEDP	13.1	$ 596.13	1.92 %	$ 18.5 B	USA
IQVIA Holdings IQV	7.57	$ 214.25	-1.05 %	$ 38.8 B	USA
CareDx, Inc CDNA	-3.54	$ 14.61	-2.6 %	$ 786 M	USA
Brainsway Ltd. BWAY	-0.24	$ 17.58	4.3 %	$ 99.4 M	Israel
Biodesix BDSX	-0.33	$ 6.33	-7.3 %	$ 821 M	USA
T2 Biosystems TTOO	-19.2	$ 0.12	-39.35 %	$ 313 K	USA
OPKO Health OPK	0.02	$ 1.42	4.04 %	$ 986 M	USA
Guardant Health GH	-3.56	$ 98.46	5.84 %	$ 12.1 B	USA
Agilent Technologies A	3.98	$ 144.14	-1.5 %	$ 43.8 B	USA
Co-Diagnostics CODX	-1.2	$ 0.41	-10.11 %	$ 12 M	USA